SSY Group's (HKG:2005) 13 products covering 16 specifications were selected in the 12th round of China's National Centralised Medicines Procurement program.
The selected products include Blonanserin Tablets, Vitamin B6 Injection, Acipimox Capsules, Doxazosin Mesylate Extended Release Tablets, Bumetanide Injection, Pentoxifylline Sustained-release Tablets, Deferasirox Dispersible Tablets and Calcium Chloride Injection, among others, according to a Hong Kong bourse filing.